Fingerprint
Dive into the research topics of 'Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Initial in vivo testing of a multitarget kinase inhibitor, regorafenib, by the Pediatric Preclinical Testing Consortium
Douglas J. Harrison, Jonathan D. Gill, Michael E. Roth, Wendong Zhang, Beverly Teicher, Stephen Erickson, Greg Gatto, Raushan T. Kurmasheva, Peter J. Houghton, Malcolm A. Smith, Edward Anders Kolb, Richard Gorlick
Research output: Contribution to journal › Article › peer-review
9
Scopus
citations